Growth Metrics

Travere Therapeutics (TVTX) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -13.32%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -10.19%
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 24.11%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 3.92%
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn -25.26%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -25.26%
Dec 31, 2025 -24.63%
Sep 30, 2025 -29.89%
Jun 30, 2025 -30.68%
Mar 31, 2025 -30.10%
Dec 31, 2024 -28.65%
Sep 30, 2024 -22.94%
Jun 30, 2024 -23.22%
Mar 31, 2024 -23.93%
Dec 31, 2023 -17.35%
Sep 30, 2023 -16.33%
Jun 30, 2023 -14.98%
Mar 31, 2023 -13.91%
Dec 31, 2022 -18.52%
Sep 30, 2022 -16.99%
Jun 30, 2022 -13.99%
Mar 31, 2022 -9.36%
Dec 31, 2021 17.92%
Sep 30, 2021 102.12%
Jun 30, 2021 300.00%
Mar 31, 2021 346.96%
Dec 31, 2020 225.77%
Sep 30, 2020 95.74%
Jun 30, 2020 -2.82%
Mar 31, 2020 -12.62%
Dec 31, 2019 -8.11%
Sep 30, 2019 -12.43%
Jun 30, 2019 -12.74%
Mar 31, 2019 -1.55%
Dec 31, 2018 -2.60%
Sep 30, 2018 22.30%
Jun 30, 2018 36.02%
Mar 31, 2018 25.29%
Dec 31, 2017 24.86%
Sep 30, 2017 611.26%
Jun 30, 2017 566.67%
Mar 31, 2017 482.25%
Dec 31, 2016 504.44%
Sep 30, 2016 -20.08%
Jun 30, 2016 -25.15%
Mar 31, 2016 -32.59%
Dec 31, 2015 -36.21%
Sep 30, 2015 -24.51%
Dec 31, 2014 426.58%
Sep 30, 2014 1,547.29%